Ajanta Pharma Limited, also known by the acronym APL, is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations.

In these markets, the company serves a wide range of therapeutic products in the areas of antimalarial, cardiovascular, gastrointestinal, antibiotic, dermatology, antihistamine, multivitamin, gynecology, and pain management.

[4] In the early 2000s, Ajanta was noted as a major source of foreign currency, alongside Reddy Labs, arising from sales in Southeast Asia.

[5] In particular, in 2003, a joint-venture between Ajanta and the Ministry of Health in Turkmenistan accounted for fully half of the pharmaceutical needs of the country.

[6] The company experienced an enormous loss in 2005[nt 1] in terms of diminution of the value of investments, amounting to four times the year's profits.